Convexity Labs

FTK

Convexity Analyst · FTK
Buymedium confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: FTK (Flotek Industries, Inc.) Date: 2026-06-13 Event Date: 2026-06-13

1. Structural Readiness

  • Conservative Entry: $20.50
  • Breakout Level: $20.50 (Confirmed breakout fired; price has held above this level)
  • Current Price: $22.66
  • Extension: +10.5% vs. conservative entry
  • ATR Context: ATR at breakout was 5.5% (High structural quality). Current ATR is 6.5% (Very High volatility).
  • Pivot Strength: Swing
  • Cap Bucket: Small

2. Thesis Layer

As of 2026-06-13, there is no named secular thesis attached to this specific setup. This is a TACTICAL, setup-led name. The conviction must be derived strictly from the quality of the technical structure (the confirmed coil breakout) and the immediate business fundamentals disclosed in the most recent filings. We do not invent a macro thesis; we judge the setup on its own merits: a confirmed breakout supported by expanding backlog and revenue guidance.

3. Business Overview

Flotek Industries operates as an innovation-driven enterprise specializing in chemical and data solutions for the energy sector. The company is organized into two primary segments:

  • Chemistry Technologies (CT): Focuses on the R&D, manufacturing, and distribution of environmentally friendly specialty chemicals designed to boost hydrocarbon extraction profitability and sanitize environments.
  • Data Analytics (DA): Provides field-deployable inline optical analyzers and cloud-based visualization platforms to generate insights into hydrocarbon fluid composition.

Key Business Drivers (Source: Earnings Transcript 2026-05-06 & SEC Filings 2026-05-07):

  • Backlog Expansion: Management has expanded its expected backlog for the remainder of 2026 to $34.1 million, with a three-year expected backlog exceeding $90 million (E1).
  • Revenue Guidance: For full-year 2026, management estimates total revenue in a range of $270 million to $290 million and adjusted EBITDA in a range of $36 million to $41 million (E2).
  • PowerTech & Digital Growth: Since closing the original PowerTech deal, 21 measurement units have been added. Additionally, a 27-unit order was secured from a large OFS customer for distributed power fleet monitoring, and a 15-unit order was secured from a major midstream customer for real-time crude quality measurement (E4, E5).
  • Market Penetration: Management expects proprietary real-time analyzers to be on more than 50% of currently active North American e-frac and natural gas-powered fleets by year-end 2026 (E6).
  • Lease Agreement: The company expects full-year 2026 revenues from a specific Lease Agreement to total approximately $27.0 million (E8, E16).
  • Contract Shortfall Fees: Related party revenues for the three months ended March 31, 2026, reflect $2.7 million in Contract Shortfall Fees because minimum purchase requirements were not met (E9). This contrasts with the $27.4 million shortfall recorded in 2025 (E20), indicating a reduction in the magnitude of this specific fee, though it remains a revenue component.
  • Disaster Recovery: A new agreement coordinates the installation of up to 50 MW of power generation equipment for federal disaster recovery, with an initial six-month term and an option to extend to four years (E10).

4. Archetype and Conviction

  • Archetype: Growth Leader
  • Rationale: The company fits the Growth Leader archetype due to the explicit expansion of backlog ($90M+ three-year), the addition of new measurement units (21 units since closing), and the aggressive guidance for market penetration (50% of active fleets). The business model is shifting from pure chemical supply to a hybrid of high-margin data analytics and recurring lease revenue.
  • Valuation Context: The financial spine indicates a forward consensus EPS of $0.57627 for FY1 and $0.9148 for FY2 (E29).
  • Conviction Stack:
  • Thesis Strength: Moderate (Tactical, no macro tailwind named, but strong operational momentum).
  • Evidence Quality: High. Multiple primary sources (earnings, SEC filings) confirm backlog growth, specific unit orders, and revenue ranges.
  • Structural Quality: High. The breakout occurred with an ATR of 5.5% (High), indicating a strong move. The current ATR of 6.5% (Very High) suggests the stock is in a high-velocity phase.
  • Rerating Potential: Moderate to High. The transition to a "Growth Leader" with a $90M+ backlog and 50% market penetration target suggests a potential multiple expansion if execution continues.

5. Invalidations, Strengtheners, and Gaps

  • Strengtheners: Confirmation of the 27-unit and 15-unit orders converting to revenue in the next quarter. Successful extension of the 50MW disaster recovery contract beyond the initial six months. Continued reduction in Contract Shortfall Fees (moving from $27.4M in 2025 to $2.7M in Q1 2026 suggests a trend, though the full year impact needs monitoring).
  • Gaps in Evidence:
  • Customer Concentration: While E12 and E13 list customer types (supermajors, midstream), the specific revenue contribution of the new PowerTech orders vs. legacy chemistry business is not fully broken out in the provided text.
  • Margin Mix: The guidance provides EBITDA ranges, but the specific margin contribution of the high-growth DA segment vs. the CT segment is not detailed in the provided evidence.
  • Lease Agreement Terms: The specific terms of the "Lease Agreement" generating $27M are not fully detailed beyond the revenue expectation.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Confirmed coil breakout with 10.5% extension; Backlog expanded to >$90M over three years; 21 new units added since PowerTech deal with specific 27-unit and 15-unit orders secured; Revenue guidance of $270M-$290M with EBITDA of $36M-$41M. Key risks: Very high current ATR (6.5%) indicating elevated volatility and potential for sharp pullbacks; Contract Shortfall Fees remain a revenue component despite reduction; Customer concentration in cyclical energy sector; Execution risk on 50% fleet penetration target. Sizing hint: Reduce position size relative to standard allocation due to very high ATR; scale in on pullbacks to support levels. Expected path: Management expects continued revenue growth from CT and DA segments through 2026; structural implication is a shift toward higher-margin data analytics and recurring lease revenue; backlog expansion supports top-line growth. Expected horizon: 6 to 12 months for the backlog and unit deployment thesis to fully reflect in financials.

Loading chart...
Exhibit 1: FTK daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for FTK.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for FTK.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: